Patriot Investment Management Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
GIC
IHL
AP
FMI
CA
FNFDCM
AC
RFA
Patriot Investment Management Group's IBB Position: Q2 2026 in Review
Patriot Investment Management Group reduced its iShares Biotechnology ETF (IBB) stake by 9.3% in Q2 2026, selling an estimated $139K and leaving 7,937 shares worth $1.51M. The position accounts for 0.09% of the portfolio, ranked #95.
Patriot Investment Management Group first reported a position in IBB in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.98M in Q3 2021. 320 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Patriot Investment Management Group held 7,937 shares of iShares Biotechnology ETF worth $1.51M as of Q2 2026.
- Patriot Investment Management Group sold 810 iShares Biotechnology ETF shares in Q2 2026, an estimated $139K.
- iShares Biotechnology ETF made up 0.09% of Patriot Investment Management Group's portfolio in Q2 2026, its #95 holding.
- Patriot Investment Management Group first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 30 quarters since.
- Patriot Investment Management Group's iShares Biotechnology ETF position peaked at $1.98M in Q3 2021.
- 320 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Patriot Investment Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.